EluRyng®
ENG + EE Vaginal Ring
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Vaginal Ring
-
Intended Duration:
- Short-Acting
- Development Stage: Single-Country Approval
- Developer(s)/researcher(s): Amneal
Details
- API: Etonogestrel + Ethinyl Estradiol
- Target: Progesterone Receptor, Estrogen Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: Ethylene Vinylacetate
- Regimen: 3 Weeks Inserted/1 Week Removed
- MPT: Not Potential MPT
- Promising Attributes: Eluryng is the sole generic of Nuvaring. Should user interest in user-controlled, reversable methods continue, Eluryng may be available at a more accessible price point than other similar rings.
Product Status
Single-Country Approval: United States
History
2019: Amneal Pharmaceuticals receives Abbreviated New Drug Approval from US FDA